Sage Journals: Discover world-class research

Abstract

French

The case of a patient who developed a severe hypotensive reaction with a persistent hemianaesthesia following the addition of lithium carbonate to her treatment regimen is described. The patient had been receiving chlorpromazine therapy for the management of hypomania and the addition of lithium carbonate to the chlorpromazine produced a severe hypotensive episode which compromised her neurological functioning. Only three doses of lithium carbonate had actually been taken by the patient. This type of hypotensive response associated with the simultaneous use of chlorpromazine and lithium has not previously been noted in the literature.

References

Cohen

, Cohen

N.H.

Lithium carbonate, Haloperidol and irreversible brain damage.

J Am Med Assoc 1974; 230: 1283–1287.

Baastrup

, Hollnagel

, Sorensen

Adverse reaction in treatment with lithium carbonate and haloperidol.

J Am Med Assoc 1976; 236: 2645–2646.

Schou

Adverse lithium neuroleptic interactions — are there permanent effects?

Hum Psychopharmacol 1990; 5: 263–265.

Miller

, Meninger

Lithium-neuroleptic neurotoxicity is dose dependent.

J Clin Psychopharmacol 1987; 72: 89–91.

Kessel

J.B.

, Verghese

, Simpson

G.M.

Neurotoxicity related to lithium and neuroleptic combinations?

A retrospective review. J Psychiatry Neurosc 1992; 17(1): 27–30.

Lishman

W.A.

In: Organic psychiatry. London: Blackwell Scientific Publications, 1987: 532–534.

Spierst

, Hirsch

S.R.

Severe lithium toxicity with “normal” serum concentrations.

Br Med J 1978; 1: 815–816.

Hayj

, Simpson

Neurotoxicity associated with therapeutic serum lithium levels.

Lancet 1982; 2: 160–161.

Strayhom

J.M.

, Nash

J.L.

Severe neurotoxicity despite “therapeutic” serum lithium levels.

Dis Nerv System 1977; 38: 107–111.

10.

Martin

C.A.

, Piascik

M.T.

First degree A-V block in patients on lithium carbonate.

Can J Psychiatry 1985; 3(2): 114–116.

11.

Jaffe

C.M.

First degree atrio-ventricular block during lithium carbonate treatment.

Am J Psychiatry 1977; 134: 88–89.

12.

Brady

H.R.

, Horgan

J.R.

Lithium and the heart, unanswered questions.

Chest 1988; 1(93): 166–169.

13.

Shader

R.I.

, DiMaschio

In: Psychotropic drug side-effects: chemical and theoretical perspectives. Baltimore MD: The Williams and Wilkins Co., 1978.

14.

Alexander

C.S.

, Nino

Cardiovascular complications in young patients taking psychotropic drugs.

Am Heart J 1969; 78: 757–769.

15.

Spring

G.K.

Neurotoxicity with combined use of lithium and thioridazine.

J Clin Psychiatry 1979; 40: 135–138.

16.

Silverstone

P.H.

, Grahame-Smith

D.G.

A review of the relationship between calcium channels and psychiatric disorders.

J Psychopharmacol 1992; 6(4): 462–482.

17.

Bell

A.J.

, Ferner

I.N.

, Eccleston

Lithium neurotoxicity at normal therapeutic levels.

Br J Psychiatry 1993; 162: 689–692.

Severe Hypotension Associated with Combined Lithium and Chlorpromazine Therapy: a Case Report and a Review

Abstract

References